Heart Test Laboratories Inc. (HSCS) Financials

$4.85

$0.22 (4.75%)

As on 25-Sep-2026 12:36EDT

Market cap

$25 Mln

Revenue (TTM)

$90 Mln

P/E Ratio

--

P/B Ratio

70.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Operating Revenue	89.50	0.00	0.00	0.02	0.01	0.01
Cost of Revenue	0.14	0.13	0.13	0.10	0.03	0.03
Gross Profit	-0.13	-0.13	-0.13	-0.08	-0.02	-0.02
Operating Expenses	9.35	8.28	8.23	6.22	6.09	4.69
Operating Profit (EBIT)	-9.48	-8.41	-8.35	-6.31	-6.11	-4.71
Other Income	--	--	--	--	--	--
Profit before Tax	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83
Provision for Tax	-3.68	-3.68	--	-0.10	484.50	-0.25
Profit after Tax (Net Income)	-10.26	-9.14	-8.77	-6.61	-6.35	-4.83
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-6.35	-4.83

Liabilities ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Shareholder's Funds	-2.03	225.53	0.21	7.32	0.23	-6.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.14	175.50	0.31	0.43	1.22	4.67
Current Liabilities	5.63	4,861.11	3.70	1.75	1.83	3.47
Total Liabilities	9.37	5,262.67	4.22	9.50	3.29	2.09

Assets ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Non-Current Assets	3.05	2,679.75	2.05	2.15	0.59	0.16
Current Assets	0.69	2,582.93	2.17	7.35	2.70	1.93
Total Assets	9.24	5,262.14	4.22	9.50	3.29	2.09
Total Debt*	4.00	3,936.65	2.99	1.04	1.57	6.16
Net Current Assets	-4.82	-2.28	-1.53	5.60	0.86	-1.54

Cashflow ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Cash From Operating Activities	--	-7.43	-7.41	-6.07	-5.77	-3.64
Cash Flow from Investing Activities	--	-0.04	-0.03	-0.13	-0.02	0.00
Cash from Financing Activities	--	8.03	2.73	10.34	6.53	3.84
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
ROCE (%)	--	-0.44	-151.86	-130.15	-667.68	-756.67
ROE (%)	--	-8.10	-233.04	-175.02	218.16	121.23
ROA (%)	-109.74	-0.35	-127.72	-103.28	-236.36	-240.40
EBIT Margin (%)	-10.59	-378,768.23	-192,013.10	-33,608.22	-118,662.45	-31,007.02
Net Margin (%)	-11.46	-211,666.47	-201,499.52	-35,511.87	-123,384.27	-33,592.57
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Revenue Growth (%)	1,431,855.20	-0.01	-0.77	2.61	-0.64	-0.44
EBIT Growth (%)	-16.77	-95.86	-33.62	-2.29	-37.12	-92.12
Net Profit Growth (%)	-4.30	-4.30	-32.70	-3.95	-31.61	-96.90
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Price / Earnings	--	--	--	--	--	--
Price / Book Value	70.85	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.14	-270.99	-0.23	0.78	0.02	--
Close Price ($)	2.18	1.95	3.51	0.09	0.89	--
High Price ($)	3.93	6.47	13.50	1.32	6.00	--
Low Price ($)	1.63	1.92	0.07	0.09	0.71	--
Market Cap ($ Cr)	24.96	--	--	--	--	--

Solvency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Debt to Equity	--	17.46	14.55	0.14	6.79	-1.02
Short term debt to equity ratio	-1.90	16.68	13.02	0.08	2.30	-0.28
Current Ratio	0.12	0.53	0.59	4.20	1.47	0.56
Quick Ratio	-71.42	0.40	0.41	3.84	1.10	0.36
Interest Coverage	-11.75	-21.72	-16.69	-17.65	-25.13	-11.99

Operating Efficiency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17
Debtors to sales (%)	--	--	100.00	4,713.40	6,201.57	16.15
Asset Turnover	9.57	0.00	0.00	0.00	0.00	0.01
Receivable days	--	183.94	36,988.57	11,743.70	11,407.93	1,233.40
Inventory Days	--	900,351.58	1,799.65	2,355.64	8,301.12	7,552.38
Payable days	--	437,150.98	1,078.63	1,947.88	8,151.24	5,462.03
Cash Conversion Cycle	--	463,384.53	37,709.59	12,151.46	11,557.81	3,323.74

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.